Author
Listed:
- Jovia L. Nierenberg
(San Francisco
San Francisco)
- Aaron W. Adamson
(Beckman Research Institute of City of Hope)
- Donglei Hu
(San Francisco)
- Scott Huntsman
(San Francisco)
- Carmina Patrick
(Beckman Research Institute of City of Hope)
- Min Li
(San Francisco)
- Linda Steele
(Beckman Research Institute of City of Hope)
- Shu Tao
(Beckman Research Institute of City of Hope)
- Yuan Chun Ding
(Beckman Research Institute of City of Hope)
- Barry Tong
(San Francisco)
- Yiwey Shieh
(Weill Cornell Medicine)
- Laura Fejerman
(Davis
Davis)
- Stephen B. Gruber
(City of Hope National Medical Center)
- Christopher A. Haiman
(University of Southern California)
- Esther M. John
(Stanford University School of Medicine
Stanford University School of Medicine
Stanford University School of Medicine)
- Lawrence H. Kushi
(Kaiser Permanente Northern California)
- Gabriela Torres-Mejía
(Instituto Nacional de Salud Pública)
- Charité Ricker
(University of Southern California)
- Jeffrey N. Weitzel
(The University of Kansas Comprehensive Cancer Center)
- Elad Ziv
(San Francisco)
- Susan L. Neuhausen
(Beckman Research Institute of City of Hope)
Abstract
Breast cancer (BC) is one of the most common cancers globally. Genetic testing facilitates screening and informs targeted risk-reduction and treatments. However, genes included in testing panels are from European-ancestry studies. We conducted a pooled case-control analysis in self-identified Hispanic/Latina women (4178 cases and 4344 controls), using whole exome sequencing and a targeted panel. We tested the association of loss of function (LoF) variants with overall, estrogen receptor (ER)-positive, and ER-negative BC risk. Using logistic regression, we found a strong association of LoF variants in FANCM with ER-negative BC (p = 4.1 × 10−7), odds ratio [confidence interval]: 6.7 [2.9–15.6]). Among known susceptibility genes, BRCA1, BRCA2, and PALB2 strongly associated with BC. FANCM was previously proposed as a possible susceptibility gene for ER-negative BC, but is not routinely tested clinically. Our results demonstrate that FANCM should be added to BC gene panels.
Suggested Citation
Jovia L. Nierenberg & Aaron W. Adamson & Donglei Hu & Scott Huntsman & Carmina Patrick & Min Li & Linda Steele & Shu Tao & Yuan Chun Ding & Barry Tong & Yiwey Shieh & Laura Fejerman & Stephen B. Grube, 2025.
"Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women,"
Nature Communications, Nature, vol. 16(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60564-0
DOI: 10.1038/s41467-025-60564-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60564-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.